The Delivery Variable
Share
How much of what presents as inconsistent response or tolerance is actually delivery variance rather than pharmacology?
Therapeutic outcome in CBPM is a multi-variable problem.
Before it ever reaches the patient, the plant itself is the first variable. Cannabis is a living organism with its own biological clock. Genetic expression is not fixed. The same strain, whether grown from seed or cloned from a mother plant, can express differently depending on environment, stress, and conditions during growth. Clones drift over successive generations. Trichome development peaks and then declines. Circadian rhythm affects resin production and terpene expression. Degradation begins before harvest. No two plants are identical, even grown side by side under the same conditions by the same grower.
Strain. Genetics. The grower's experience and conditions. How it was cultivated. Light schedule, UV exposure, growing techniques, stress factors, nutrients, and additives applied during cultivation. How it was harvested. Harvest timing. Cannabinoid ratio. Terpene profile. Flavonoids. Minor cannabinoids. Temperature. Internal state. Set and setting. How it was consumed. Device condition. Accessories used. Cross-contamination. Symptom state on the day.
Every gram is different. Concentration varies across the plant and degrades from the moment it is harvested, packaged, transported, and stored before it ever reaches the patient. No two grams are identical, even from the same batch.
And then there is the consumption method itself. Some patients are not using a vaporiser at all. Combustion is unregulated, untested as a delivery method for CBPM, and introduces an entirely separate set of variables that nobody is measuring. Burning flower is not the same as vaporising it. The temperature, the compounds produced, and what actually reaches the lung are incomparable.
The device can be standardised. The engineering exists. The certifications exist. But not every patient is using a certified device. Uncertified, unregulated hardware is in use across the patient population with no baseline standard at all.
And even a certified device that is not maintained is no longer operating to its certified standard. Residue builds. The airpath contaminates. Screens and gauzes block and degrade. Seals fail. O-rings wear.
Even the delivery method within the device changes the outcome. Whip, balloon, direct draw. Each one delivers differently. Each one introduces its own variables. A balloon fills and sits. Compounds begin to degrade before the patient inhales. A whip cools across its length, terpene dropout increases with distance and temperature drop.
And accessories, third party mouthpieces, whips, balloons, cooling units, water pipe adapters, dosing capsules, introduce additional variables that fall outside the original certification entirely. What reaches the lung is no longer what the device was designed to deliver.
And even once the vapour reaches the lung, the variables do not stop. Lung health and capacity differ between every patient. Someone whose lung health is compromised in any way will absorb differently to someone with healthy lung function. The causes are too numerous to list. The variable is real regardless of the cause. The endocannabinoid system is unique to each individual. Metabolism, tolerance built over time, other medications and interactions, fed or fasted state, hydration levels. All of it affects what the body does with what it receives.
You cannot standardise the plant. You cannot standardise the patient.
But you can maintain the device. Cleaning is not optional hygiene. It is the difference between a medical device performing as specified and one that isn't. That is the one variable in the entire chain with a solution.
Clinicians, patients, prescribers. This is a conversation the sector needs to have. Where are you seeing this in your practice, your research, or your own experience?